Clinical Trial Update: Efficacy and Tolerability of Artesunate Amodiaquine Versus Chloroquine in the Treatment of Uncomplicated Plasmodium Vivax Malaria [Phase 3]

View source ↗

Summary

Phase 3 trial comparing artesunate-amodiaquine to chloroquine for efficacy and tolerability in uncomplicated Plasmodium vivax malaria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmodium Vivax Malaria

Drugs mentioned

• Artesunate-amodiaquine (artesunate-amodiaquine)
• Chloroquine (chloroquine)

Snippet

Sponsor: Sanofi | Conditions: Malaria | Phase 3 | Status: COMPLETED